UMC
LABU icon

United Maritime Capital’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

United Maritime Capital’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,100
Closed -$792K – 61
2021
Q4 		$792K Sell
1,100
-50
-4% -$47.9K 0.91% 23
2021
Q3 		$1.27M Buy
1,150
+300
+35% +$369K 1.42% 17
2021
Q2 		$1.25M Buy
+850
New +$1.18M 0.95% 21

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Traynor Capital Management Malvern, Pennsylvania $1.7B AUM 39.15% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return

United Maritime Capital's LABU Position: Q1 2022 in Review

United Maritime Capital sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2022, closing a stake of 1,100 shares — an estimated $792K sold.

United Maritime Capital first reported a position in LABU in Q2 2021 and held it in 3 quarters. The position peaked at $1.27M in Q3 2021. 32 funds tracked by Wall St. Rank hold LABU as of Q1 2022.

  • United Maritime Capital reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2022 after selling out during the quarter.
  • United Maritime Capital sold 1,100 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2022, an estimated $792K.
  • United Maritime Capital first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2021 and held it in 3 quarters.
  • United Maritime Capital's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $1.27M in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2022.

Based on United Maritime Capital's 13F filing for Q1 2022, filed 12 May 2022.